• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RetCAD深度学习系统用于检测可转诊糖尿病视网膜病变和年龄相关性黄斑变性的真实世界评估。

Real-world evaluation of RetCAD deep-learning system for the detection of referable diabetic retinopathy and age-related macular degeneration.

作者信息

Taylor Joshua R, Drinkwater Jocelyn, Sousa David Cordeiro, Shah Vaibhav, Turner Angus W

机构信息

Lions Outback Vision, Lions Eye Institute, Nedlands, Western Australia, Australia.

Centre for Ophthalmology and Visual Science, University of Western Australia, Crawley, Western Australia, Australia.

出版信息

Clin Exp Optom. 2024 Aug 12:1-6. doi: 10.1080/08164622.2024.2385565.

DOI:10.1080/08164622.2024.2385565
PMID:39134384
Abstract

CLINICAL RELEVANCE

The challenges of establishing retinal screening programs in rural settings may be mitigated by the emergence of deep-learning systems for early disease detection.

BACKGROUND

Deep-learning systems have demonstrated promising results in retinal disease detection and may be particularly useful in rural settings where accessibility remains a barrier to equitable service provision. This study aims to evaluate the real-world performance of Thirona RetCAD for the detection of referable diabetic retinopathy and age-related macular degeneration in a rural Australian population.

METHODS

Colour fundus images from participants with known diabetic retinopathy or age-related macular degeneration were randomly selected from ophthalmology clinics in four rural Australian centres. Grading was confirmed retrospectively by two retinal specialists. RetCAD produced a quantitative measure (0-100) for DR and AMD severity. The area under the ROC curve (AUC) was calculated. Sensitivity, specificity, and positive and negative predictive values were calculated at a pre-defined cut-point of ≥50.

RESULTS

A total of 150 images from 82 participants were included. The mean age (SD) was 64.0 (12.8) years. Seventy-nine (52.7%) eyes had evidence of referable DR, while 54 (36.0%) had evidence of referable AMD. The AUC for referable DR detection was 0.971 (95% CI 0.950-0.936) with a sensitivity of 86.1% (76.8%-92.0%) and a specificity of 91.6% (82.8%-96.1%) at the pre-defined cut-point. Using the Youden Index method, the optimal cut-point was 41.2 (sensitivity 93.7%, specificity 90.1%). The AUC for the detection of referable AMD was 0.880 (0.824-0.936). At the pre-defined cut-point sensitivity was 88.9% (77.8%-94.8%) and specificity was 66.7% (56.8%-75.3%). The optimal cut-point was 52.6 (sensitivity 87.0%, specificity 75.0%).

CONCLUSION

RetCAD is comparable with but does not outperform equivalent deep-learning systems for retinal disease detection. RetCAD may be suitable as an automated screening tool in a rural Australian setting.

摘要

临床相关性

深度学习系统用于早期疾病检测的出现,可能会减轻在农村地区建立视网膜筛查项目的挑战。

背景

深度学习系统在视网膜疾病检测中已显示出有前景的结果,在农村地区可能特别有用,因为在这些地区可及性仍然是公平提供服务的障碍。本研究旨在评估Thirona RetCAD在澳大利亚农村人群中检测可转诊糖尿病视网膜病变和年龄相关性黄斑变性的实际性能。

方法

从澳大利亚四个农村中心的眼科诊所中随机选择患有已知糖尿病视网膜病变或年龄相关性黄斑变性参与者的彩色眼底图像。由两名视网膜专家进行回顾性分级确认。RetCAD对糖尿病视网膜病变和年龄相关性黄斑变性的严重程度产生定量测量值(0 - 100)。计算ROC曲线下面积(AUC)。在预先定义的≥50的切点处计算敏感性、特异性以及阳性和阴性预测值。

结果

共纳入来自82名参与者的150张图像。平均年龄(标准差)为64.0(12.8)岁。79只(52.7%)眼睛有可转诊糖尿病视网膜病变的证据,而54只(36.0%)有可转诊年龄相关性黄斑变性的证据。可转诊糖尿病视网膜病变检测的AUC为0.971(95%可信区间0.950 - 0.936),在预先定义的切点处敏感性为86.1%(76.8% - 92.0%),特异性为91.6%(82.8% - 96.1%)。使用约登指数法,最佳切点为41.2(敏感性93.7%,特异性90.1%)。可转诊年龄相关性黄斑变性检测的AUC为0.880(0.824 - 0.936)。在预先定义的切点处敏感性为88.9%(77.8% - 94.8%),特异性为66.7%(56.8% - 75.3%)。最佳切点为52.6(敏感性87.0%,特异性75.0%)。

结论

RetCAD在视网膜疾病检测方面与等效的深度学习系统相当,但并不优于它们。RetCAD可能适合作为澳大利亚农村地区的一种自动筛查工具。

相似文献

1
Real-world evaluation of RetCAD deep-learning system for the detection of referable diabetic retinopathy and age-related macular degeneration.RetCAD深度学习系统用于检测可转诊糖尿病视网膜病变和年龄相关性黄斑变性的真实世界评估。
Clin Exp Optom. 2024 Aug 12:1-6. doi: 10.1080/08164622.2024.2385565.
2
Artificial intelligence for diagnosing exudative age-related macular degeneration.人工智能在渗出性年龄相关性黄斑变性诊断中的应用。
Cochrane Database Syst Rev. 2024 Oct 17;10(10):CD015522. doi: 10.1002/14651858.CD015522.pub2.
3
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.光学相干断层扫描(OCT)用于检测糖尿病视网膜病变患者的黄斑水肿。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008081. doi: 10.1002/14651858.CD008081.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Blue-light filtering intraocular lenses (IOLs) for protecting macular health.用于保护黄斑健康的蓝光滤过型人工晶状体
Cochrane Database Syst Rev. 2018 May 22;5(5):CD011977. doi: 10.1002/14651858.CD011977.pub2.
6
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.抗氧化维生素和矿物质补充剂用于延缓年龄相关性黄斑变性的进展。
Cochrane Database Syst Rev. 2017 Jul 31;7(7):CD000254. doi: 10.1002/14651858.CD000254.pub4.
7
Fenofibrate for diabetic retinopathy.非诺贝特治疗糖尿病性视网膜病变。
Cochrane Database Syst Rev. 2023 Jun 13;6(6):CD013318. doi: 10.1002/14651858.CD013318.pub2.
8
Aflibercept for neovascular age-related macular degeneration.阿柏西普用于治疗新生血管性年龄相关性黄斑变性。
Cochrane Database Syst Rev. 2016 Feb 8;2(2):CD011346. doi: 10.1002/14651858.CD011346.pub2.
9
Surgery for cataracts in people with age-related macular degeneration.年龄相关性黄斑变性患者的白内障手术
Cochrane Database Syst Rev. 2017 Feb 16;2(2):CD006757. doi: 10.1002/14651858.CD006757.pub4.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.